Cargando…

Safety and Efficacy of Intermittent High-Dose Liposomal Amphotericin B Antifungal Prophylaxis in Haemato-Oncology: An Eight-Year Single-Centre Experience and Review of the Literature

Triazoles remain first-line agents for antifungal prophylaxis in high-risk haemato-oncology patients, but their use is increasingly contraindicated due to drug–drug interactions and additive toxicities with novel treatments. In this retrospective, single-centre, observational study, we present our e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Youngs, Jonathan, Low, Jen Mae, Whitney, Laura, Logan, Clare, Chase, Janice, Yau, Ting, Klammer, Matthias, Koh, Mickey, Bicanic, Tihana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767522/ https://www.ncbi.nlm.nih.gov/pubmed/33371513 http://dx.doi.org/10.3390/jof6040385

Ejemplares similares

Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B
por: van de Peppel, Robert J, et al.
Publicado: (2020)

When Azoles Cannot Be Used: The Clinical Effectiveness of Intermittent Liposomal Amphotericin Prophylaxis in Hematology Patients
por: Batchelor, R, et al.
Publicado: (2021)

P20 COVID-19-associated pulmonary aspergillosis (CAPA): review of utility of local CAPA guideline and MDT in directing diagnosis and antifungal stewardship
por: Hawkins, Lois, et al.
Publicado: (2022)

Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B
por: Adler-Moore, Jill, et al.
Publicado: (2019)

Liposomal amphotericin B—the present
por: Maertens, J, et al.
Publicado: (2022)

Liposomal amphotericin B—the past
por: Brüggemann, R J, et al.
Publicado: (2022)

Liposomal amphotericin B—the future
por: Hoenigl, M, et al.
Publicado: (2022)

A Case of Hæmato-Colpos
por: Duer, C.
Publicado: (1898)

In vitro antifungal susceptibilities of Candida species to liposomal amphotericin B, determined using CLSI broth microdilution, and amphotericin B deoxycholate, measured using the Etest
por: Lovero, Grazia, et al.
Publicado: (2017)

Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever
por: Yoshida, Isao, et al.
Publicado: (2020)

Liposomal Amphotericin B Treatment and the Leishmaniases
por: Berman, Jonathan
Publicado: (2019)

Amphotericin-B/amphotericin-B-liposomal: Lack of efficacy: 2 case reports
Publicado: (2022)

Haemato-oncology and burnout: an Italian survey
por: Bressi, C, et al.
Publicado: (2008)

Design of an Antifungal Surface Embedding Liposomal Amphotericin B Through a Mussel Adhesive-Inspired Coating Strategy
por: Alves, Diana, et al.
Publicado: (2019)

Improving antibiotic stewardship in COVID-19: Bacterial co-infection is less common than with influenza
por: Youngs, Jonathan, et al.
Publicado: (2020)

2109. Liposomal Amphotericin B-associated Nephrotoxicity in Obese and Non-obese Patients
por: Tritle, Brandon, et al.
Publicado: (2019)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

Amphotericin-B-liposomal: No improvement: case report
Publicado: (2022)

Amphotericin-B-liposomal: Anaphylaxis: case report
Publicado: (2022)

Protective and antifungal properties of Nanodisk-Amphotericin B over commercially available Amphotericin B()
por: Cho, Do-Yeon, et al.
Publicado: (2017)

Antifungal effect of triclosan on Aspergillus fumigatus: quorum quenching role as a single agent and synergy with liposomal amphotericin-B
por: Tamimi, Roya, et al.
Publicado: (2022)

Fingolimod Potentiates the Antifungal Activity of Amphotericin B
por: Wei, Lu-Qi, et al.
Publicado: (2021)

The importance of cleanrooms for the treatment of haemato-oncological patients
por: Holý, Ondřej, et al.
Publicado: (2012)

Optimal management of acute kidney injury in critically ill patients with invasive fungal infections being treated with liposomal amphotericin B
por: Armstrong-James, Darius, et al.
Publicado: (2020)

Liposomal amphotericin B as a treatment for human leishmaniasis
por: Balasegaram, Manica, et al.
Publicado: (2012)

Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
por: Ubals, Maria, et al.
Publicado: (2021)

Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis
por: Hamada, Noboru, et al.
Publicado: (2021)

2105. Liposomal Amphotericin B Use Before and After Implementation of Voriconazole Prophylaxis in Cancer Patients
por: Shams, Madeeha, et al.
Publicado: (2019)

Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
por: Faustino, Célia, et al.
Publicado: (2020)

Design of amphotericin B oral formulation for antifungal therapy
por: Liu, Min, et al.
Publicado: (2017)

In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates
por: Montagna, Maria Teresa, et al.
Publicado: (2014)

Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient
por: Anderson, Anthony, et al.
Publicado: (2017)

Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
por: Morizot, Gloria, et al.
Publicado: (2016)

Amphotericin B liposome-induced acrocyanosis and elevated serum creatinine
por: Zhang, Xiangcai, et al.
Publicado: (2016)

Unveiling the Synergistic Interaction Between Liposomal Amphotericin B and Colistin
por: Teixeira-Santos, Rita, et al.
Publicado: (2016)

Successful treatment of cutaneous protothecosis with liposomal amphotericin and oral itraconazole
por: McMullan, Brendan, et al.
Publicado: (2016)

Renal Recovery following Liposomal Amphotericin B-Induced Nephrotoxicity
por: Personett, Heather A., et al.
Publicado: (2019)

Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B
por: Groll, Andreas H, et al.
Publicado: (2019)

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
por: Jarvis, Joseph N, et al.
Publicado: (2022)

Amphotericin-B liposomal: Acute kidney injury: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f1htd6s3dppm92pvb3vk108ddr